Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CMS Targets Fraud Among DME Suppliers In Florida, Los Angeles

This article was originally published in The Gray Sheet

Executive Summary

All durable medical equipment suppliers in three counties in South Florida and four in the Los Angeles area will have to reapply for CMS-855S numbers that allow them to bill Medicare for beneficiaries' DME, prosthetics, orthotics and other medical supplies. The effort is part of a demonstration project launched by CMS July 2

You may also be interested in...



Trial Run Of Expanded Medicare DME Claims Review Planned For FY 2009

The Centers for Medicare and Medicaid Services plans to expand reviews of certain durable medical equipment claims in fiscal 2009, based on recommendations from the HHS Office of the Inspector General

Trial Run Of Expanded Medicare DME Claims Review Planned For FY 2009

The Centers for Medicare and Medicaid Services plans to expand reviews of certain durable medical equipment claims in fiscal 2009, based on recommendations from the HHS Office of the Inspector General

OIG on medical supplier fraud

An HHS Office of Inspector General 1report released March 3 finds persisting problems in Medicare compliance among suppliers of durable medical equipment, prosthetics, orthotics and supplies (DMEPOS), including hospital beds, wheelchairs and artificial limbs. OIG inspected 905 suppliers in Los Angeles County, one of the "hotspots" of supplier problems, and found in addition to other violations that 13% of suppliers did not have a physical facility or were closed during repeated visits. OIG recommends that CMS conduct more unannounced site visits, increase prepayment reviews of DMEPOS claims, and establish minimum inventory requirements for product types. CMS says it has already addressed a number of the identified fraud vulnerabilities (2"The Gray Sheet" July 9, 2007, p. 14)

Latest Headlines
See All
UsernamePublicRestriction

Register

MT024991

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel